OHDSI Home | Forums | Wiki | Github

Researchers


How to interpret the confusion matrix of an unbalanced data classification? The false positives are much more than the true positives (2)
Defining a Townsend local area deprivation quintile in ATLAS as provided by the THIN database(?) (5)
Best practice when using cdm data (2)
Why OMOP? Publications /research insights that show the power of the OMOP CDM (1)
Statins may reduce risk of death among adults 75 and older (1)
Analyzing visits : variations by source (10)
LEGEND - HTN - 101 for beginners (2)
Mother (Father?) and baby link (14)
Solving “Error: object ‘is.factor.ff’ is not exported by 'namespace:ff'” (3)
Glucose [Mass/volume] concept - mapping source values for cohort definition (4)
Java version issue in running Patient-Level-Prediction packages (10)
Patient Level Prediction - ATLAS (3)
Call for collaborators: inflammatory bowel disease (IBD) phenotyping (10)
Best practices for electronic phenotype validation (3)
[COVID19 Study-a-thon] Paper on characteristics of pediatric population with COVID-19 (2)
Rare diseases / Orphan diseases (1)
ICU data, anyone? ( 2 ) (21)
Characterization of Oral Antibiotic and Isotretinoin Therapy for Acne (5)
Has the homepage address changed? (http://omop.org/HOI) (5)
Concept set for HIG codes for COVID research (3)
Study launch: Evaluating the Iodine-131 exposure effect on the occurrence of secondary cancer in survivors of thyroid cancer (4)
List of boutique companies hire-able to do epi studies (RWE studies?) (2)
Feasibility of Network studies that use the NOTE, NOTE_NLP, and Flowsheets (3)
How to find the ancestor_concept_id of the condition_concept_id in the condition_occurrence table? (13)
CDC Collaboration (3)
Cohort pathway : why in the same first circle,the same drug sometimes tend to be in central, sometimes tend to be for second circel? (2)
Adding a new cohort from Synthea generated csv files to an existing CDM (3)
The meaning of 'minDaysAtRisk' argument (3)
Standardizing procedures (call for non-US based collaborators) (18)
Dexamethasone Cohort Building (4)
t